ABT-046 structure
|
Common Name | ABT-046 | ||
---|---|---|---|---|
CAS Number | 1031336-60-3 | Molecular Weight | 350.41400 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H22N4O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of ABT-046ABT-046 is a potent, selective, and orally bioavailable Diacylglycerol acyltransferase 1 (DGAT-1 ) inhibitor (IC50= 8 nM).IC50 value: 8 nM [1]Target: DGAT-1Oral administration at doses ≥0.03 mg/kg significantly reduced postprandial triglycerides in mice following an oral lipid challenge. Further assessment in both acute and chronic safety pharmacology and toxicology studies demonstrated a clean profile up to high plasma levels, thus culminating in the nomination of 14 as clinical candidate ABT-046. |
Name | 2-[4-[4-(7-aminopyrazolo[1,5-a]pyrimidin-6-yl)phenyl]cyclohexyl]acetic acid |
---|---|
Synonym | More Synonyms |
Description | ABT-046 is a potent, selective, and orally bioavailable Diacylglycerol acyltransferase 1 (DGAT-1 ) inhibitor (IC50= 8 nM).IC50 value: 8 nM [1]Target: DGAT-1Oral administration at doses ≥0.03 mg/kg significantly reduced postprandial triglycerides in mice following an oral lipid challenge. Further assessment in both acute and chronic safety pharmacology and toxicology studies demonstrated a clean profile up to high plasma levels, thus culminating in the nomination of 14 as clinical candidate ABT-046. |
---|---|
Related Catalog | |
References |
Molecular Formula | C20H22N4O2 |
---|---|
Molecular Weight | 350.41400 |
Exact Mass | 350.17400 |
PSA | 93.51000 |
LogP | 4.30820 |
Storage condition | 2-8℃ |
CS-1213 |
ABT 046 |
ABT-046||ABT 046|ABT046 |
trans-{4-[4-(7-aminopyrazolo[1,5-a]pyrimidin-6-yl)phenyl]cyclohexyl}acetic acid |
ABT-046 |